DYAI
Dyadic International, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.52
+3.89%Margins
Gross margin
30.4%
EBITDA margin
-206.9%
EBIT margin
-213.6%
Net margin
-219.5%
FCF margin
-213.2%
319.3%
Return on equity
-116.6%
Return on assets
-279.0%
Return on invested capital
0.48x
Asset turnover
-$7.4M
Cash from operations
$0.08
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026